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Aims: To update the analysis of the cohort mortality and cancer incidence study of employees in the
Australian petroleum industry.
Methods: Employees from 1981 to 1996 were traced through the Australian National Death Index and the
National Cancer Statistics Clearing House. Cause specific mortality and cancer incidence were compared
with those of the Australian population by means of standardised mortality ratios (SMRs) and standardised
incidence ratios (SIRs). Associations between increased incidence of specific cancers and employment in
the petroleum industry were tested by trends according to period of first employment, duration of
employment, latency, and hydrocarbon exposure, adjusting for personal smoking history where
appropriate. Total follow up time was 176 598 person-years for males and 10 253 person-years for
females.
Results: A total of 692 of the 15 957 male subjects, and 16 of the 1206 female subjects had died by the
cut off date, 31 December 1996. In males, the all-cause SMR and the SMRs for all major disease
categories were significantly below unity. There was a non-significant increase of the all-cancer SIR (1.04,
95% CI 0.97 to 1.11). There was a significant increase of the incidence of melanoma (SIR 1.54, 95% CI
1.30 to 1.81), bladder cancer (SIR 1.37, 95% CI 1.00 to 1.83), and prostate cancer (SIR 1.19, 95% CI
1.00 to 1.40), and a marginally significant excess of pleural mesothelioma (SIR 1.80, 95% CI 0.90 to
3.22), leukaemia (SIR 1.39, 95%CI 0.91 to 2.02), and multiple myeloma (SIR 1.72, 95% CI 0.96 to 2.84).
Conclusions: Most cases of mesothelioma are probably related to past exposure to asbestos in refineries.
The melanoma excess may be the result of early diagnosis. The excess bladder cancer has not been
observed previously in this industry and is not readily explained. The divergence between cancer incidence
and cancer mortality suggests that the ‘‘healthy worker effect’’ may be related to early reporting of curable
cancers, leading to increased likelihood of cure and prolonged mean survival time.
H
ealth Watch is a health surveillance programme of
employees of the major sectors of the Australian
petroleum industry. The mortality and cancer incidence
of the Health Watch cohort to 31 December 1989 has been
reported previously.1 2 In this report we present the mortality
and cancer incidence of the Health Watch cohort updated to
the end of 1996.
METHODS
Health Watch was established in 1980–83 with an interview
survey of employees of Australian Institute of Petroleum
member companies. Information was obtained on work areas
and tasks, and on smoking. Head office staff and those at
facilities with fewer than 10 employees were excluded.
Subjects were admitted to the cohort on completion of five
years of service. More members were admitted to the cohort
following three further surveys, the fourth survey being
completed in 2000. At these surveys existing cohort members
still employed were reinterviewed. Although participation is
voluntary, the overall participation rate was over 90%. Follow
up information is obtained twice yearly from Australian
Institute of Petroleum (AIP) member companies, giving
details of retirements, redundancies, and transfers. Those no
longer employed by member companies are followed by
periodic mailings to obtain an update of smoking and other
information.
Jobs are coded according to the system developed by the
American Petroleum Institute.3 4 Total hydrocarbon exposure
was derived from job codes and was ranked by a committee
of industry occupational hygienists into seven categories of
exposure. The distribution of person-years across these
categories is unequal, most jobs being in the fourth ranked
category. It is a somewhat crude measure of exposure: a more
detailed, quantitative estimate of benzene exposures has been
undertaken as part of a nested case-control study of
leukaemia cases in the cohort.5
Names of cohort members are periodically submitted to the
National Death Index (NDI) for matching to identify
deceased members and ICD-9 coding for principal cause of
death. The National Cancer Statistics Clearing House
(NCSCH), a consolidated database from all State and
Territory cancer registries, is searched for cancer registrations.
Standardised mortality ratios (SMRs) and standardised
cancer incidence ratios (SIRs), adjusted by age and calendar
year of occurrence by five year groupings, were generated by
comparison of mortality and cancer incidence with national
rates. Exact 95% confidence intervals were calculated: these
do not rely on large numbers for validity.6 7 Tests for constant
SMRs and SIRs across several categories were carried out
using Poisson regression.8 Cancers with raised SIRs were
analysed to detect trends in relation to period of first
employment and duration of employment. To allow for
uncertainties in latency, estimates were made of variation in
incidence with time since first employment. Analyses were
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: CI, confidence interval; Exp, expected; NCSCH,
National Cancer Statistics Clearing House; NDI, National Death Index;
Obs, observed; RIR, relative incidence ratio; SIR, standardised cancer
incidence ratio; SMR, standardised mortality ratio
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also performed for increasing hydrocarbon rank score—both
for the highest ranked job ever held, and the rank score of the
job held longest. The measure of effect in these analyses was
relative incidence ratios (RIR), being the measure relative to
a baseline stratum, adjusted by age, calendar year and, where
appropriate, smoking. Poisson regression was used for the
relative incidence rate calculations using the method
described by Berry9 and Breslow and Day.10
Names of subjects whose vital status was uncertain were
submitted to the Australian Electoral Commission in 2001
(that is, five years after the cut off date). Subjects still on the
electoral roll were categorised as still alive. Subjects whose
names appeared on the NCSCH but not on the NDI were
categorised as alive and their follow up continued to the cut
off date. A total of 1258 males (8%) and 323 females (27%)
remained untraced and their person-years of observation
were censored from the date of last contact, if that date
preceded the cut off date. Less than 2% of male person-time
was lost from censoring.
RESULTS
Table 1 shows details of the cohort at 31 December 1996.
Table 2 shows mortality by major cause. For men the all-
cause SMR was 0.68 (95% CI 0.63 to 0.73). Mortality by each
major disease category was also significantly below unity in
males. In females the all-cause SMR was 0.70 (95% CI 0.40 to
1.14). Thirteen of the 16 female deaths were due to cancer,
with an all-cancer SMR of 1.22 (95% CI 0.65 to 2.08).
Table 3 shows cancer mortality and cancer incidence in
males. The SMR was significantly less than unity (0.84, 95%
CI 0.74 to 0.94). There were no cancers of any major
anatomical site for which the SMR significantly exceeded
unity. The lung cancer SMR was significantly less than unity
(0.66, 95% CI 0.51 to 0.85).
The SIR for all cancers was 1.04, a non-significant increase
(95% CI 0.97 to 1.11). There were significant excesses of the
incidence of melanoma (SIR 1.54, 95% CI 1.30 to 1.81),
bladder cancer (SIR 1.37, 95% CI 1.00 to 1.83), and prostate
cancer (SIR 1.19, 95% CI 1.00 to 1.40). Pleural mesothelioma
(SIR 1.80, 95% CI 0.90 to 3.22), all leukaemias combined (SIR
1.39, 95% CI 0.91 to 2.02), and multiple myeloma (SIR 1.72,
95% CI 0.96 to 2.84) occurred in marginally significant
excess. The incidence of lung cancer was significantly below
unity (SIR 0.65, 95% CI 0.51 to 0.82).
All 11 pleural cancers were mesotheliomas. There were no
peritoneal mesotheliomas. Not all occupational histories of
the 11 cases of mesothelioma are sufficiently detailed to
assess whether asbestos exposure during employment in the
petroleum industry was responsible. Ten cases occurred in
refinery workers, of whom six were fitters, welders, or
maintenance workers, and two had probably had significant
asbestos exposure prior to entering the petroleum industry.
Three other refinery workers had had possible prior asbestos
exposure before entering the industry (in one case this was in
the petroleum industry in another country). The occupation
of one refinery worker is not known. In the one case who was
not a refinery worker, asbestos exposure may have occurred
prior to entering the industry but not since. Inspection of the
work histories of the individual cases suggests that most of
the asbestos exposures occurred prior to the 1970s.
Both lung cancer incidence and lung cancer mortality were
significantly reduced compared with the general male
population. Lung cancer incidence was strongly associated
with the amount of tobacco use. Former smokers had a
relative incidence rate below that of those who smoked 1–19
cigarettes per day. There was only one lung cancer among
lifelong non-smokers (1 per 59 635 person-years).
The incidence of melanoma was significantly raised overall,
and the excess was significantly increased in refinery,
terminal, and airport personnel. There was no significant
association with decade of hire, duration of employment,
time since hire, or hydrocarbon exposure ranking. Despite the
excess incidence the mortality rate from melanoma was low,
although not significantly different from that of the general
population (SMR 0.82, 95% CI 0.41 to 1.47).
Bladder cancer incidence was significantly raised. As table 4
shows, increased incidence (but non-significant) was found
in all workplace types except onshore production. After
adjustment for the effects of age, calendar period of follow
up, and smoking, the relative incidence ratio (RIR) of bladder
cancer showed no significant association with period of hire,
duration of employment, or time since hire. Based on the
highest hydrocarbon rank score ever held, there is a clear and
significant trend of increasing incidence with increased
hydrocarbon exposure (p = 0.02). In the analysis based on
the total hydrocarbon ranking of the job held longest, and
there is a marginally significant (p = 0.09) tendency for
increasing relative incidence with increasing hydrocarbon
ranking.
Main messages
N An excess of mesothelioma was found, and is probably
the legacy of past exposures to asbestos in the
petroleum industry. In contrast to earlier findings in
this cohort, the excess of leukaemias is not statistically
significant.
N There is an excess bladder cancer in the Australian
petroleum industry, and a work related cause cannot
be excluded.
N The ‘‘healthy worker effect’’, at least in the case of
cancer, may be due to diagnosis occurring at earlier
stages of cancer in occupational cohorts, with
increased cure rates and prolonged mean survival
time, rather than to lowered cancer incidence.
Policy implications
N Further exploration of the findings on bladder cancer in
the petroleum industry, including attempts to identify
any causal exposure, should receive priority.
N Policies of elimination of asbestos exposure need to be
maintained.
N The finding of normal or above-normal rates of cancer
incidence but significantly low mortality indicates that
there is great scope for reduction in cancer mortality
from screening for some cancers, such as melanoma
and bowel and bladder cancer.
Table 1 Employment details and vital status of cohort
members
Males Females
Persons alive 14006 867
Vital status at cut off date unknown 1258 323
Deaths in Australia 684 16
Deaths overseas 8 0
Total 15956 1206
Total person-years 176598 10253
Median duration of employment (y) 16.3 13.0
Mortality and cancer incidence in the Australian petroleum industry 151
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There was a non-significant excess of all leukaemias
combined (SIR 1.39, 95% CI 0.91 to 2.02). This contrasts
with the previous report of this cohort in which there was
a significant leukaemia excess.2 The numbers of the
main individual leukaemia types (acute/chronic lymphatic,
acute/chronic myeloid) were too low for meaningful
analysis. However, there was a significant excess of ‘‘all
other leukaemias’’—that is, those not included in the
four leukaemia types specified above. The excess of all
leukaemias combined was present in all workplace types
except onshore production, but was not significant in any
(table 5). There is a marginally significant trend towards
increasing relative incidence with earlier periods of first
employment (p = 0.09) but no association with duration of
employment or time since hire. The RIR of leukaemia
increases significantly with increasing rank score of hydro-
carbon exposure, based on the highest rank score ever held
(p = 0.05). Based on the rank score of the job held longest
there is a marginally significant increase in risk with
increased hydrocarbon exposure (p = 0.07). Analyses of
leukaemia in table 5 show RIRs after adjustment for
smoking; because of uncertainty as to whether smoking is
an independent cause of leukaemia, RIRs were also com-
puted without adjusting for smoking, with no material
difference in the results.
The incidence of prostatic cancer shows no association
with any workplace type, decade of hire, duration of
employment, time since hire, or hydrocarbon exposure
ranking. Mortality from prostatic cancer was close to unity
(SMR 0.98, 95% CI 0.58 to 1.55).
Mortality from heart disease was significantly below unity
(SMR 0.71, 95% CI 0.62 to 0.82). Ischaemic heart disease
mortality was strongly related to the degree of tobacco use,
with the reduction in former smokers almost down to that of
lifelong non-smokers.
Shift workers showed no difference in all-cause mortality,
all-cancer mortality, heart disease mortality, mortality from
accidents and/or violence, and cancer incidence compared
with non-shift workers. Relative to the general population
the SMRs were significantly below unity, but cancer
incidence was slightly increased (SIR 1.09, 95% CI 0.95 to
1.25).
Table 2 Mortality by major cause
Cause (ICD-9)
Males Females
Obs/Exp SMR 95% CI Obs/Exp SMR 95% CI
Cancer (140–208) 280/334.2 0.84 0.74 to 0.94 13/10.7 1.22 0.65 to 2.08
Ischaemic heart disease (410–414) 188/263.0 0.71 0.62 to 0.82 2/2.9 0.68 0.08 to 2.47
Stroke (430–438) 28/48.6 0.58 0.38 to 0.83 0
Respiratory disease (460–519) 30/58.5 0.51 0.35 to 0.73 0
Digestive system diseases* (570–579) 18/33.5 0.54 0.32 to 0.85 0
Accidents/violence (800–999) 71/115.3 0.62 0.48 to 0.78 0
All other causes 69/156.6 0.44 0.34 to 0.56 1/9.2 0.1 0 to 0.6
All causes 684/1009.7 0.68 0.63 to 0.73 16/22.8 0.70 0.40 to 1.14
*Disorders of liver and biliary tract, pancreas, gastrointestinal haemorrhage other than from peptic ulcer, and intestinal malabsorption.
Table 3 Standardised incidence ratios (SIRs) and standardised mortality ratios (SMRs) for major cancer types, with 95%
confidence intervals (95% CI); males
Cancer site (ICD-9) Obs/Exp cancers SIR 95% CI Obs/Exp deaths SMR 95% CI
Lip, oral cavity, pharynx (140–149) 39/52.9 0.74 0.52 to 1.00 6/13.0 0.46 0.17 to 1.00
Oesophagus (150) 6/11.8 0.51 0.19 to 1.11 6/11.0 0.54 0.20 to 1.18
Stomach (151) 26/24.5 1.06 0.69 to 1.56 15/14.6 1.03 0.58 to 1.70
Colon (153) 64/68.5 0.93 0.72 to 1.19 27/32.4 0.83 0.55 to 1.21
Rectum (154) 49/47.9 1.02 0.76 to 1.35 11/13.3 0.83 0.41 to 1.48
Liver (155) 6/7.1 0.84 0.31 to 1.84 4/6.9 0.58 0.16 to 1.49
Gall bladder (156) 4/4.4 0.92 0.25 to 2.35 3/2.1 1.41 0.29 to 4.12
Pancreas (157) 16/15.2 1.05 0.60 to 1.71 10/14.6 0.69 0.33 to 1.26
Larynx (161) 14/15.2 0.92 0.50 to 1.55 2/5.3 0.38 0.05 to 1.36
Lung (162) 73/111.9 0.65 0.51 to 0.82 62/93.6 0.66 0.51 to 0.85
Pleura (163) 11/6.1 1.80 0.90 to 3.22 6/3.1 1.96 0.72 to 4.27
Connective tissue (171) 6/7.4 0.81 0.30 to 1.76 2/2.2 0.93 0.11 to 3.35
Melanoma (172) 143/92.9 1.54 1.30 to 1.81 11/13.4 0.82 0.41 to 1.47
Non-melanotic skin (173) * 2/3.5 0.56 0.07 to 2.04
Prostate (185) 137/115.3 1.19 1.00 to 1.40 18/18.4 0.98 0.58 to 1.55
Testis (186) 14/11.3 1.24 0.68 to 2.08 1/0.82 1.22 0.03 to 6.8
Bladder (188) 46/33.5 1.37 1.00 to 1.83 6/6.1 0.98 0.36 to 2.13
Kidney (189) 28/24.5 1.14 0.76 to 1.65 13/8.8 1.49 0.79 to 2.54
Eye (190) 5/2.7 1.85 0.60 to 4.31 
Brain/nervous system (191–192) 16/17.0 0.94 0.54 to 1.53 15/14.2 1.06 0.59 to 1.74
Non-Hodgkin’s lymphoma (200–202) 32/33.6 0.95 0.65 to 1.35 11/13.4 0.82 0.40 to 1.47
Multiple myeloma (203) 15/8.7 1.72 0.96 to 2.84 8/4.9 1.63 0.70 to 3.22
All leukaemias (204–208) 27/19.5 1.39 0.91 to 2.02 16/10.9 1.47 0.84 to 2.39
Acute lymphatic leukaemia (204.0) 1/1.2 0.84 0.02 to 4.68 2/1.1 1.81 0.22 to 6.56
Chronic lymphatic leukaemia (204.1) 7/7.2 0.97 0.39 to 2.00 0/1.8 0
Acute myeloid leukaemia (205.0) 6/5.8 1.04 0.38 to 2.27 5/4.90 1.03 0.33 to 2.39
Chronic myeloid leukaemia (205.1) 4/3.4 1.18 0.32 to 3.02 4/2.0 2.03 0.55 to 5.20
All other leukaemias 9/1.9 4.65 2.13 to 8.83 5/1.2 4.33 1.40 to 10.1
Other and unspecified sites 36/50.9 0.70 0.50 to 0.98 25/27.8 0.90 0.58 to 1.33
All malignant (excluding 173) 813/782.7 1.04 0.97 to 1.11 280/334.2 0.84 0.74 to 0.94
*Not a registrable disease in most Australian cancer registries.
Expected value could not be computed due to grouping of ICD-9 190 in national data into ICD 190–199.
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At the cut-off date 16 females had died, 13 from cancer.
There was a marginally significant increase in all-cancer
incidence (SIR 1.33 95% CI 0.98 to 1.78). There was a
statistically significant increase in melanoma incidence (SIR
2.75, 95% CI 1.42 to 4.80) (table 6). The SIR for bladder
cancer was 7.13, based on three cases (95% CI 1.47 to 20.82).
The all-cancer SMR was 1.22 (95% CI 0.65 to 2.08) (table 2).
DISCUSSION
Low SMRs are common in occupational cohorts, a finding
commonly called ‘‘the healthy worker effect’’. The ‘‘healthy
worker effect’’ is reported to abate11 12 or even to go into
reverse13 with aging of occupational cohorts, and the all-
cause SMR of 0.68 compared with 0.63 as reported in the
cohort up to 19891 suggests that this is also occurring in this
cohort.
The ‘‘healthy worker effect’’ has been attributed to healthy
individuals being selected for employment.14 15 The discovery
of a ‘‘healthy worker effect’’ was based on mortality studies,
so that the proposition that occupational cohorts have lower
disease incidence than the general population is speculative,
and can only be clarified by concurrent analyses of disease
incidence and mortality. Cancer mortality is an imperfect
measure of the occurrence of cancer, being a function not
only of cancer incidence, but also of cancer survival and the
frequency of death from competing causes. A strength of the
present study has been its ability concurrently to examine
mortality and cancer incidence; this is in contrast to nearly all
studies of the industry in other countries, which have had
mortality as their single end-point.
The finding of an all-cancer SIR of 1.04 (an increase of
marginal significance) with an all-cancer SMR of 0.84
(significantly reduced) indicates that at least in the case of
cancer, the low SMR is not the result of low cancer incidence.
An alternative explanation of the low SMR is prolonged
survival. The prospect of cure and the survival time from
cancer is strongly related to the site of the cancer and the
staging at the time of diagnosis. As shown in table 3, the
strongest contributor to the difference between SIR and SMR
for cancer is melanoma, in which the incidence of disease in
Australia is increasing, whereas the mortality rate is stable.
This divergence has been attributed to earlier diagnosis.16
Other contributors to the difference between SIR and SMR in
this cohort have been cancers of the colon, rectum, bladder,
Table 4 Bladder cancer: SIR by workplace type and RIR by period of hire, duration of
employment, years since hire, highest hydrocarbon ranking job held, and hydrocarbon
ranking of job held longest, adjusted for age, calendar year; RIRs also adjusted for
smoking
Workplace type Person-years Obs/Exp SIR 95% CI
Refinery 69795 21/14.2 1.48 0.92 to 2.26
Terminal 73373 18/15.1 1.19 0.71 to 1.88
Airport 6877 4/1.4 2.85 0.78 to 7.29
Onshore production 19629 2/2.2 0.9 0.11 to 3.27
Offshore production 6924 1/0.6 1.61 0.04 to 8.96
Period of hire Person-years Cases RIR* 95% CI
Post-1975 79838 9 1
1965–74 60283 13 0.82 0.32 to 2.08
1955–64 24837 16 0.98 0.35 to 2.75
Pre-1955 11640 8 0.68 0.21 to 2.24
Years of employment Person-years Cases RIR 95% CI
5–9 45836 4 1
10–15 43718 10 1.45 0.44 to 4.80
15–19 32976 6 0.74 0.20 to 2.81
20–24 21475 2 0.25 0.04 to 1.45
25+ 32593 24 0.99 0.29 to 3.40
Years since hire Person-years Cases RIR` 95% CI
5–9 37624 4 1
10–14 41147 5 0.68 0.18 to 2.61
15–19 34372 6 0.57 0.15 to 2.21
20–24 23741 6 0.47 0.11 to 1.94
25+ 39714 25 0.44 0.12 to 1.65
Highest hydrocarbon ranking job Person-years Cases RIR1 95% CI
1 33991 6 1
2 14986 1 0.79 0.09 to 6.68
3 1912 0
4 80583 23 2.06 0.83 to 5.08
5 6430 2 2.65 0.53 to 13.2
6 28420 9 2.21 0.78 to 6.26
7 10252 5 3.74 1.14 to 12.3
Hydrocarbon ranking longest job Person-years Cases RIR 95% CI
1 45922 8 1
2 15856 1 0.66 0.08 to 5.34
3 2959 0 0
4 74258 25 2.02 0.91 to 4.48
5 4723 1 1.32 0.17 to 10.6
6 25187 8 1.84 0.69 to 4.92
7 5011 2 2.11 0.45 to 9.95
Tests for trend: *p = 0.63, p = 0.60, `p = 0.24, 1p = 0.02, p = 0.09.
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and larynx, cancers which have quite a good prognosis if
diagnosed early. Thus a plausible explanation of the ‘‘healthy
worker effect’’, at least in the case of cancer, may be earlier
diagnosis than in the general population.
Higher social class has been shown to be associated with
earlier presentation of cancer.17 It is possible that secure
employment also confers an advantage in socioeconomic
status. Economic factors and health promotion programmes
in the petroleum industry may lead to early presentation and
diagnosis of cancer and hence the low cancer mortality found
in this cohort.
The occurrence of a number of cases of mesothelioma in
the Health Watch cohort is consistent with other recently
published studies of oil refinery workers,18–21 and is indicative
of past asbestos exposure. Although the likelihood of such
exposure in some cohort members might suggest a risk of
raised lung cancer incidence, such a risk is not apparent in
this cohort. Lung cancer is the only cancer which has a
significantly low SIR, despite a smoking prevalence in the
cohort very similar to that of the general population (age
adjusted prevalence of 24.1% compared with the Australian
population rate of 28.2%).22 The concurrence of mesothelioma
and a significantly low rate of lung cancer has been a
consistent finding in petroleum industry studies, as has been
shown by Tsai and colleagues.20 Moreover such studies have
also shown smoking prevalences similar to those of the
comparison populations. The consistently low lung cancer
rates suggest that asbestos is making little if any contribution
to lung cancer in the petroleum industry. There is some
support for the view that asbestos can cause lung cancer at
exposures too low to cause asbestosis, although this question
Table 5 Leukaemia: SIR by workplace type and RIR by period of hire, duration of
employment, years since hire, highest hydrocarbon ranking job held, and hydrocarbon
ranking of job held longest, adjusted for age, calendar year; RIRs also adjusted for
smoking
Workplace type Person-years O/E SIR 95% CI
Refinery 69795 10/8.1 1.24 0.59 to 2.27
Terminal 73373 14/8.6 1.63 0.89 to 2.73
Airport 6877 1/0.8 1.24 0.03 to 6.92
Onshore production 19629 1/1.5 0.66 0.02 to 3.67
Offshore production 6924 1/0.5 2.15 0.05 to 11.97
Period of hire Person-years Cases RIR* 95% CI
Post-1975 79838 7 1
1965–74 60283 8 1.11 0.36 to 3.39
1955–64 24837 5 1.51 0.34 to 6.69
Pre-1954 11640 7 4.03 0.81 to 20.1
Years of employment Person-years Cases RIR 95% CI
5–9 45836 4 1
10–15 43718 5 1.14 0.30 to 4.41
15–19 32976 4 1.08 0.24 to 4.82
20–24 21475 4 1.53 0.32 to 7.32
25+ 32593 10 1.97 0.43 to 9.13
Years since hire Person-years Cases RIR` 95% CI
5–9 37624 4 1
10–14 41147 3 0.63 0.14 to 2.89
15–19 34372 3 0.69 0.14 to 3.51
20–24 23741 7 2.14 0.48 to 9.55
25+ 39714 10 1.33 0.26 to 6.88
Highest hydrocarbon ranking job Person-years Cases RIR1 95% CI
1 33991 1 1
2 14986 1 3.17 0.19 to 51.9
3 1912 0 0
4 80583 16 7.14 0.94 to 54.1
5 6430 1 6.65 0.41 to 106.7
6 28420 6 6.9 0.82 to 58.0
7 10252 2 7 0.63 to 77.9
Hydrocarbon ranking longest job Person-years Cases RIR 95% CI
1 45922 2 1
2 15856 1 1.79 0.16 to 20.1
3 2959 0 0
4 74258 17 4.93 1.14 to 21.4
5 4723 1 5.11 0.46 to 56.4
6 25187 6 4.63 0.93 to 23.2
7 5011 0 0
Tests for trend—*p = 0.09, p = 0.34, `p = 0.37, 1p = 0.05, p = 0.07
Table 6 SIRs and SMRs for major cancer types; females
Cancer site (ICD-9) Obs/Exp SIR 95% CI
Colon (153) 4/2.5 1.63 0.44 to 4.16
Melanoma (172) 12/4.4 2.75 1.42 to 4.80
Breast (174) 12/11.7 1.02 0.53 to 1.79
Cervix (180) 3/1.9 1.61 0.33 to 4.71
Bladder (188) 3/0.4 7.13 1.47 to 20.82
Other 12/13.7 0.88 0.45 to 1.54
All cancers 46/34.5 1.33 0.98 to 1.78
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remains controversial.23–25 The findings in this cohort—in
which there has been only one registered death from
asbestosis—and in other cohorts in this industry suggest
that low level asbestos exposure confers a risk of mesothe-
lioma but not of asbestos related lung cancer.
A possible explanation for the low lung cancer incidence
may be differences in the amount smoked—that is, smokers
in the petroleum industry smoke less, and ex-smokers quit
sooner, than smokers in the general population: lung cancer
incidence is very sensitive to these variables.26 The occurrence
of only one lung cancer among life-long non-smokers
reaffirms that lung cancer in people who have never been
active smokers is a rare disease.
The increased melanoma incidence is unrelated to work-
place type, duration of employment, or hydrocarbon expo-
sure, so that occupational causation is unlikely. A plausible
alternative explanation is early reporting, resulting from
periodic medical examinations, as well as health promotion
programmes advising workers of the warning signs of skin
cancer, would be expected to lead to a high reporting rate. If
this leads to melanomas being reported at an earlier age than
in the general population an increased SIR could result.
Despite the excess melanoma incidence the mortality rate is
low (but not significantly).
There was also a significant excess of melanoma in
females. An occupational cause is even less likely in female
workers, and early reporting is therefore the likely explana-
tion of the raised SIR. That being so, early reporting is likely
to have occurred in male workers also.
The increase in bladder cancer incidence is unlikely to be
the result of confounding from smoking, despite the
important role of smoking in the causation of this cancer.
As discussed above, the smoking prevalence in the cohort is
comparable with that of the Australian male population.
Moreover the low incidence of lung cancer and non-
malignant respiratory disease suggests that smokers in the
cohort may on the whole have a low level of tobacco use.
Evidence for an occupational cause is inconclusive. No
tendency to increased incidence is apparent from increasing
duration of employment, although there is a trend towards
increasing incidence with increasing hydrocarbon exposure.
A possible contributing factor to the raised incidence could
be an increased reporting rate, as with melanoma. The
absence of an increased mortality rate for bladder cancer
(SMR 0.98, 95% CI 0.36 to 2.13) would be consistent with
early reporting with a high cure rate. Bladder cancer often
responds well to treatment: South Australian cancer registry
data show that bladder cancer cases outnumber bladder
cancer deaths more than 2 to 1.16 Accordingly the increased
bladder cancer incidence may be related to early reporting.
This may be a vindication of the practice of periodic medical
surveillance of employees in the industry, especially if regular
medical testing includes urine testing for the presence of
haematuria.
Nevertheless an occupational cause must be considered.
Although excess risk of bladder cancer has not been
documented previously in this industry, most previous
studies have been of cancer mortality rather than incidence.
Even in this study bladder cancer mortality was not raised. A
potential cause of bladder cancer is exposure to polycyclic
aromatic hydrocarbons (PAHs), which have been associated
with bladder cancer in the aluminium reduction industry.27
PAHs are present in a number of diesel and fuel oils, but the
heaviest concentrations occur in the furfural extraction units
in the lubrication oil refineries, of which there are four in
Australia. However, only 11 of the 46 bladder cancers
occurred in employees of these refineries, and work in a
furfural extraction unit was not mentioned in any of the job
histories.
Interpretation of the leukaemia excess is made difficult by
the conflicting results of dose-response analysis. Overall the
excess was not statistically significant. RIR increased with
hydrocarbon rank score but not with duration of employ-
ment. A possible explanation is that brief but high benzene
exposures may be causally related to leukaemia. On the other
hand the dose-response gradient may be partly due to a
chance effect. The RIR estimates in table 5 are relative to
exposures in the lowest category, where there were very few
cases, indeed only a single case for hydrocarbon ranking of
job held longest. Using an external comparison, the SIR for
leukaemia in the lowest exposure category (category 1) was
very low. Combining the two lowest exposure categories, the
SIR was 0.46, with a 95% CI of 0.09 to 1.34. Thus if the true
SIR were near the upper confidence limit, the trend of
increasing risk with increasing hydrocarbon exposure in
table 5 would almost be eliminated.
The absence of a significant excess of leukaemia contrasts
with the previous report of this cohort,2 and with the findings
of a concurrent case-control study nested within the cohort.28
Because of this the leukaemia findings have been presented
in some detail. Three leukaemia cases (all chronic lymphatic
leukaemia) notified by cohort members, and confirmed as
real cases, were excluded from the analysis as they were not
registered with the NCSCH, so that the leukaemia incidence
rate is probably an underestimate. The numbers of individual
leukaemia types in this cohort are too low for a causal
association to be fully evaluated. As shown in table 3, the
only category of leukaemia in significant excess is ‘‘all other
leukaemias’’, that is, those not classified as acute or chronic
myeloid leukaemia or acute or chronic lymphatic leukaemia.
This finding prompted a review of ‘‘all other leukaemias’’ by a
haematologist, who was provided with the histological
reports. This review suggested that three of the ‘‘all other
leukaemias’’ were actually chronic lymphatic leukaemias,
making 10 such cases in all, and three were acute myeloid
leukaemias, making nine such cases in all. The association
between leukaemia and quantitative estimates of benzene
exposure is examined in the separate case-control study.
The significantly low SMR from ischaemic heart disease in
shift workers is of interest in view of prior epidemiological
evidence that shift work is a risk factor for heart disease.29
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